company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10864000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10864000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,308000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1415000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-87000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9228000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9228000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-65000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-20618000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26943000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6260000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6260000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,109000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,12000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,121000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,121000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2847000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10201000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10201000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-1097000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3614000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1864000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5820000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5820000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5815000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13951000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8123000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8123000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,83000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,61000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,145000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,145000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2448000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16271000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16271000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,445000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,106000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2007000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,10242000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3471000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3471000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-23000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-23185000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13909000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-791000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10090000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10090000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-4309000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-73000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3609000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-773000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-773000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14334000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14458000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14458000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,185000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,109000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3015000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,680000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10469000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10469000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9092000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24643000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,791000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16341000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16341000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,4309000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-21000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,130000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-4857000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-439000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-439000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5433000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13192000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13192000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,256000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-284000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9126000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3984000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3984000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8732000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6041000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2692000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2692000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,94000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1027000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-442000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,679000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,679000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5997000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6052000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6052000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,168000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1006000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7480000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12248000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12248000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-69000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3666000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15605000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-330000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11540000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11540000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11826000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,99000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11925000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11925000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 16:04:02+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11217000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12276000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12276000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,157000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2131000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3536000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6342000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6342000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-40000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10868000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10206000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1275000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1977000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1977000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3661000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1079000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2582000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2582000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5737000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,136000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,109000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3481000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5803000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,47000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9704000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1930000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11675000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11675000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2645000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-508000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2035000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11053000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11053000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,167000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2451000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6197000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7030000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7030000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,2000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1666000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5318000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-8000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3646000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3646000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-6000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,322000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,316000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,316000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3068000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,11198000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14093000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2895000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2072000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4604000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2532000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3040000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8365000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5325000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4962000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8001000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8001000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,64000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,109000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,911000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1005000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7922000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7922000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14863000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7025000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2029000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5809000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5809000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18533000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1481000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20014000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20014000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,6283000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5429000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5429000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,57000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,889000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-142000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4515000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4515000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8742000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6485000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2262000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2262000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-15000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1906000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1891000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1891000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4886000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10137000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,53000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1610000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-595000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8959000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8959000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9367000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8350000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1023000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1023000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,128000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2274000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2402000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2402000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:26:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7580000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14649000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14649000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,44000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3519000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3874000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7102000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7102000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3284000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12550000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9266000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9266000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,106600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-829000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,105771000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,105771000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,107935000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8731000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8731000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,109000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1421000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1439000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8600000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3201000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8100000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4865000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4865000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,182000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3191000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3373000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3373000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-362000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11672000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11672000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,40000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,260000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3654000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6172000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13890000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13890000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-65000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-58023000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-53088000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-53088000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-310000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,671000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,361000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,361000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-66617000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15164000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15164000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,45000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2259000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9024000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3726000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3726000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-565000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3378000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2482000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2487000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3948000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3948000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1175000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,326000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1501000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1501000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 14:04:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6173000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,4901000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4901000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,49000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,110000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3675000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9363000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,18098000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,18098000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-369000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16029000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22402000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1068000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7072000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7072000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,171000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3073000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3244000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3244000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,28414000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14621000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14621000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,568000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1839000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-489000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12660000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12660000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-142000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28936000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10990000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-53000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-18141000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-18141000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-171000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,818000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,647000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,647000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30154000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18135000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18135000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,43000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,221000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1932000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1111000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14828000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14828000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4046000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5487000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6536000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,10000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2987000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2987000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1175000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1262000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,87000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,87000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-17728000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22832000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22832000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,47000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,343000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2645000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,955000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18842000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18842000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3260000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6320000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-353000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2707000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2707000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,138000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,138000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,138000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 15:02:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15997000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16281000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16281000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,89000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,179000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1846000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2983000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11184000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11184000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1839000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12744000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2461000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8444000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8444000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1501000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1501000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1501000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4241000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11528000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11528000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,175000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,312000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2008000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8525000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17558000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17558000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-179000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19208000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2920000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,21949000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,21949000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,22658000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-323000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,22335000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,22335000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26726000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4503000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4503000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,172000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,247000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2005000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3775000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-5854000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-5854000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,1000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14106000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4380000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-102000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9827000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9827000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2332000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2332000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2332000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13349000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14219000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14219000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,172000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,238000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2462000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2820000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8527000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8527000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14136000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1252000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12881000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12881000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,47750000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,950000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48700000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q1,2017-01-01,2017-03-31,2017-05-08 15:02:04+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,53054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16886000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16886000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,172000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,287000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2326000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4434000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9667000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9667000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-21000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33070000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9737000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,1252000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22102000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22102000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,118000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,118000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,118000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-31651000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15134000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15134000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,178000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,258000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5519000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3251000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12430000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12430000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-189000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6502000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8654000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1963000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1963000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,85750000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,562000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86312000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86312000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,75845000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19543000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19543000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,182000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,250000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2302000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6290000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10519000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10519000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-115000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-68215000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,12000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10934000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57384000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57384000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,500000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,73000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,573000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,573000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-67330000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25777000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,186000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,308000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2903000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2727000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19653000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19653000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-35000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4327000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20289000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15927000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15927000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1725000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,249000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1476000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1476000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q1,2018-01-01,2018-03-31,2018-05-09 14:10:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5202000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18446000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18446000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,191000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,287000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2084000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1989000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13895000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13895000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-186000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12427000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14146000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1533000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1533000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1725000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,450000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1275000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1275000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-13637000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29597000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29597000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,195000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,233000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2085000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7948000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35032000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35032000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-41000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26404000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16920000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9525000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9525000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-575000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10353000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,53400000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,740000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,63918000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,63918000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,19361000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27432000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27432000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,198000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,167000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2331000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,751000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23985000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23985000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-104000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19456000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16393000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3167000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3167000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1337000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1337000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1337000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25815000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31054000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,176000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,193000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3317000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,370000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26998000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26998000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-93000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3018000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,18992000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15881000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15881000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,19477000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,563000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20040000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20040000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q1,2019-01-01,2019-03-31,2020-05-08 17:41:36+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,8923000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37629000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37629000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,181000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,386000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5385000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7176000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24501000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24501000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-87000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22365000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22278000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22278000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,414000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,414000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,414000.0
BioCryst Pharmaceuticals Inc,BCRX,549300Z0INP1Z5NP6J59,0000882796,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1809000.0
